1 Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol. 2006;30(12):1502–12.
2 Agaimy A, Hartmann A. Mesenchymale Tumoren der Harnblase. Der Pathologe. 2016;37:61–70.
3 Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds). WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC press; 2013. p.83–4.
4 Brunn H. Two interesting benign lung tumors of contradictory histopathology. Remarks on the necessitiy for maintaining the chest tumor registry. J Thorac Cardiovasc Surg. 1939;9:119–31.
5 Roth JA. Reactive pseudosarcomatous response in urinary bladder. Urology. 1980;16(6):635–7.
6 Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous myofibroblastic proliferations of the bladder. A clinicopathologic study of 42 cases. Am J Surg Pathol. 2006;30:787–94.
7 Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428–37.
8 Cheville J, Folpe A. Inflammatory myofibroblastic tumour. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds). WHO Classification of tumours of the urinary system and male genital organs. 4th ed. Lyon: IARC press; 2016. p.124–5.
9 Alderman M, Kunju L P. Inflammatory myofibroblastic tumor of the bladder. Arch Pathol Lab Med. 2014;138:1272–7.
10 Leuschner I. Inflammatorischer myofibroblastischer Tumor. Pathologe. 2010;31:106–8.
11 Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20(5):592–603.
12 Chun JY, Teoh, Chan NH, Cheung HY, Hou SSM, Ng CF. Inflammatory Myofibroblastic Tumors of the urinary bladder: a systematic review. Urology. 2014;84:503–8.
13 Rasalkar DD, Chu WCW, To K, Cheng FWT, Li CK. Inflammatory myofibroblastic tumor: an imaging dilemma (2010:5b). Eur Radiol. 2010;20:2057–8.
14 Schöffski P, Gelderblom H, Blay J-Y, Strauss S J, Stacchiotti S, Rutkowski P, et al. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Lancet Respir Med. 2018;6:431–41.
15 Schmitz K, Schildhaus H-U (2015) Molekularpathologie der Weichgewebstumoren: Beitrag zur Diagnostik und Therapieprädiktion. Pathologe 36:126–36.
16 Raja N S, Lee T, Kaffenberger S, Kraft K, Udager A, Ivancic V. Localized Inflammatory Myofibroblastic Tumor Involving the Genitourinary System: Adolescent Case Series and Review. Urology 2018;122:162–4.
17 Nagumo Y, Maejima A, Toyoshima Y, Komiyama M, Yonemori K, Yoshida A, Fujimoto H. Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report. Int Journal of Surgery Case Reports. 2018;48:1–4.